CMND Key Statistics, Chart & Performance
The current stock price of CMND is 1.24 USD. In the past month the price decreased by -47.23%. In the past year, price decreased by -97.8%.
CMND Technical Analysis
CMND Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CMND. The financial health of CMND is average, but there are quite some concerns on its profitability.
CMND Financial Highlights
Over the last trailing twelve months CMND reported a non-GAAP Earnings per Share(EPS) of -30.64. The EPS decreased by -1439.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -102% | ||
| ROE | -379.95% | ||
| Debt/Equity | 0 |
CMND Forecast & Estimates
CMND Ownership
CMND Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 31.12 | 987.61B | ||
| JNJ | JOHNSON & JOHNSON | 20.48 | 574.955B | ||
| MRK | MERCK & CO. INC. | 21.74 | 292.01B | ||
| PFE | PFIZER INC | 9.01 | 153.798B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.99 | 123.713B | ||
| ZTS | ZOETIS INC | 18.54 | 56.1B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.49 | 25.427B | ||
| VTRS | VIATRIS INC | 6.15 | 17.921B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.75 | 12.337B | ||
| AXSM | AXSOME THERAPEUTICS INC | 223.72 | 9.236B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About CMND
Company Profile
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
Company Info
CLEARMIND MEDICINE INC
101-1220 West 6Th Avenue
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16042601566
CLEARMIND MEDICINE INC / CMND FAQ
What does CMND do?
Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2021-08-10. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.
What is the current price of CMND stock?
The current stock price of CMND is 1.24 USD. The price decreased by -8.15% in the last trading session.
What is the dividend status of CLEARMIND MEDICINE INC?
CMND does not pay a dividend.
What is the ChartMill rating of CLEARMIND MEDICINE INC stock?
CMND has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Which stock exchange lists CMND stock?
CMND stock is listed on the Nasdaq exchange.